CRH is trading at $91.27, up 5.46%, in pre-market on October 29, 2026, versus the $86.54 previous close; no specific catalyst has been confirmed. - No reliable report identified a new overnight announcement explaining the move. - CRH’s Q3 2026 results are scheduled before the U.S. market opens, with a conference call at 8:00 a.m. EDT. Available coverage did not confirm results or guidance explaining the rise. - Mixed broader-market signals do not establish a direct cause for CRH.